Stay updated with breaking news from Biocon Generics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
'Peter has a comprehensive understanding of the Biocon Group, having led Syngene for 5 years, taking it through its very successful IPO in 2015,' says Mazumdar-Shaw
Stocks to watch: Shares of firms like Infosys, RIL, ONGC, Tata Motors, Coal India, IDFC First, and others will be in focus on Monday's trade.
For the Nifty, the short term outlook looks positive, say analysts. The index is likely to face a hurdle at 19,500 on the higher side and then at 19,650. On the lower side, support is at 19,300-19,250
Biocon Limited announced that its wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.s oral solid dosage manufacturing facility, located in Cranbury, New Jersey, U.S., effective from September 1, 2023.
Biotechnology major Biocon on Saturday said its unit has acquired Eywa Pharma Inc's oral solid dosage manufacturing facility in the US for USD 7.7 million (over Rs 63 crore). Biocon Generics Inc has acquired Eywa's ranbury-based plant effective September 1 2023, the Bengaluru-based company